FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995667035> ?p ?o ?g. }

• W1995667035 endingPage "1682" @default.
• W1995667035 startingPage "1673" @default.
• W1995667035 abstract "Therapies for hormone-independent prostate and breast cancer are limited, with the effectiveness of the taxanes compromised by toxicity, lack of oral bioavailability and drug resistance. This study aims to identify and characterise new microtubule disruptors, which may have improved efficacy relative to the taxanes in hormone-independent cancer. 2-Methoxy-3-O-sulphamoyl-17β-cyanomethyl-oestra-1,3,5(10)-triene (STX641), 2-methoxy-3-hydroxy-17β-cyanomethyl-oestra-1,3,5(10)-triene (STX640) and 2-methoxyoestradiol-3,17-O,O-bis-sulphamate (STX140) were all potent inhibitors of cell proliferation in a panel of prostate and breast cancer cell lines. STX641 and STX640 significantly inhibited tumour growth in the MDA-MB-231 xenograft model. STX641 inhibited both in vitro and in vivo angiogenesis. Despite good in vivo activity, STX641 was not as potent in vivo as STX140. Therefore, STX140 was evaluated in the prostate hormone-independent PC-3 xenograft model. STX140 had superior efficacy to docetaxel, 2-MeOE2 and bevacizumab. In contrast to vinorelbine, no significant toxicity was observed. Furthermore, STX140 could be dosed daily over a 60-day period leading to tumour regression and complete responses, which were maintained after the cessation of dosing. This study demonstrates that STX641 and STX140 have considerable potential for the treatment of hormone-independent breast and prostate cancer. In contrast to the taxanes, STX140 can be dosed orally, with no toxicity being observed even after prolonged daily dosing." @default.
• W1995667035 created "2016-06-24" @default.
• W1995667035 creator A5004708346 @default.
• W1995667035 creator A5013687413 @default.
• W1995667035 creator A5017572010 @default.
• W1995667035 creator A5021421298 @default.
• W1995667035 creator A5030539301 @default.
• W1995667035 creator A5055207921 @default.
• W1995667035 creator A5057398969 @default.
• W1995667035 creator A5067225147 @default.
• W1995667035 creator A5068004095 @default.
• W1995667035 creator A5082393921 @default.
• W1995667035 date "2007-11-20" @default.
• W1995667035 modified "2023-10-06" @default.
• W1995667035 title "The therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers" @default.
• W1995667035 cites W103592546 @default.
• W1995667035 cites W1502777806 @default.
• W1995667035 cites W1505876740 @default.
• W1995667035 cites W1758017998 @default.
• W1995667035 cites W1820104968 @default.
• W1995667035 cites W1964663716 @default.
• W1995667035 cites W1966108836 @default.
• W1995667035 cites W1973044764 @default.
• W1995667035 cites W1974744898 @default.
• W1995667035 cites W1975784580 @default.
• W1995667035 cites W1983964043 @default.
• W1995667035 cites W1989989204 @default.
• W1995667035 cites W2003292783 @default.
• W1995667035 cites W2015662278 @default.
• W1995667035 cites W2048132932 @default.
• W1995667035 cites W2055344124 @default.
• W1995667035 cites W2058484250 @default.
• W1995667035 cites W2059294866 @default.
• W1995667035 cites W2062204672 @default.
• W1995667035 cites W2067754613 @default.
• W1995667035 cites W2075488301 @default.
• W1995667035 cites W2075557130 @default.
• W1995667035 cites W2075866838 @default.
• W1995667035 cites W2087065591 @default.
• W1995667035 cites W2087408753 @default.
• W1995667035 cites W2091856435 @default.
• W1995667035 cites W2095542113 @default.
• W1995667035 cites W2104648430 @default.
• W1995667035 cites W2111622585 @default.
• W1995667035 cites W2124023047 @default.
• W1995667035 cites W2139149338 @default.
• W1995667035 cites W2145185329 @default.
• W1995667035 cites W2145687358 @default.
• W1995667035 cites W2154966585 @default.
• W1995667035 cites W2157769714 @default.
• W1995667035 cites W2169992085 @default.
• W1995667035 cites W2404021914 @default.
• W1995667035 cites W3186551549 @default.
• W1995667035 doi "https://doi.org/10.1038/sj.bjc.6604100" @default.
• W1995667035 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2360283" @default.
• W1995667035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18026194" @default.
• W1995667035 hasPublicationYear "2007" @default.
• W1995667035 type Work @default.
• W1995667035 sameAs 1995667035 @default.
• W1995667035 citedByCount "26" @default.
• W1995667035 countsByYear W19956670352012 @default.
• W1995667035 countsByYear W19956670352013 @default.
• W1995667035 countsByYear W19956670352014 @default.
• W1995667035 countsByYear W19956670352015 @default.
• W1995667035 countsByYear W19956670352018 @default.
• W1995667035 countsByYear W19956670352023 @default.
• W1995667035 crossrefType "journal-article" @default.
• W1995667035 hasAuthorship W1995667035A5004708346 @default.
• W1995667035 hasAuthorship W1995667035A5013687413 @default.
• W1995667035 hasAuthorship W1995667035A5017572010 @default.
• W1995667035 hasAuthorship W1995667035A5021421298 @default.
• W1995667035 hasAuthorship W1995667035A5030539301 @default.
• W1995667035 hasAuthorship W1995667035A5055207921 @default.
• W1995667035 hasAuthorship W1995667035A5057398969 @default.
• W1995667035 hasAuthorship W1995667035A5067225147 @default.
• W1995667035 hasAuthorship W1995667035A5068004095 @default.
• W1995667035 hasAuthorship W1995667035A5082393921 @default.
• W1995667035 hasBestOaLocation W19956670351 @default.
• W1995667035 hasConcept C121608353 @default.
• W1995667035 hasConcept C126322002 @default.
• W1995667035 hasConcept C143998085 @default.
• W1995667035 hasConcept C150903083 @default.
• W1995667035 hasConcept C181389837 @default.
• W1995667035 hasConcept C207001950 @default.
• W1995667035 hasConcept C2776235491 @default.
• W1995667035 hasConcept C2776694085 @default.
• W1995667035 hasConcept C2777802072 @default.
• W1995667035 hasConcept C2778239845 @default.
• W1995667035 hasConcept C2780192828 @default.
• W1995667035 hasConcept C2780350996 @default.
• W1995667035 hasConcept C2780394083 @default.
• W1995667035 hasConcept C2781190966 @default.
• W1995667035 hasConcept C29730261 @default.
• W1995667035 hasConcept C502942594 @default.
• W1995667035 hasConcept C530470458 @default.
• W1995667035 hasConcept C71924100 @default.
• W1995667035 hasConcept C86803240 @default.
• W1995667035 hasConcept C98274493 @default.

• next